CD44, CD133, BMI1 and ALDH are considered frontline markers for detection of CSCs in OSCC, and other head and neck squamous cell carcinomas (HNSCCs) [5, 13–15]. This evidence concerns the gene BMI1 and head and neck squamous cell carcinoma.